Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KAT6A | Q92794 | 2/20 | 0.35 |
| ▸ | CTSS | P25774 | 1/20 | 0.34 |
| ▸ | P2RX7 | Q99572 | 8/20 | 0.34 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.34 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.34 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.34 |
| ▸ | AURKA | O14965 | 2/20 | 0.33 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.33 |
| ▸ | HCAR1 | Q9BXC0 | 1/20 | 0.33 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.33 |
| ▸ | WNT3A | P56704 | 1/20 | 0.33 |
| ▸ | PARP1 | P09874 | 1/20 | 0.33 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.32 |
| ▸ | MPL | P40238 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21401285 | 0.75 | ESR1 (0.35) | TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL3417739 | 0.73 | TSHR (0.41) | P2RX7TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL31257137 | 0.72 | TRPA1 (0.32) | CTNNB1WNT3A | |
| SCHEMBL3751615 | 0.72 | L3MBTL1 (0.41) | HDAC8 | |
| SCHEMBL3976340 | 0.72 | TRPA1 (0.32) | CTNNB1WNT3A | |
| SCHEMBL697432 | 0.71 | TAAR1 (0.44) | KAT6ACTSSP2RX7TAS1R3TAS1R1 | |
| SCHEMBL25870465 | 0.70 | CTSS (0.44) | KAT6ACTSSP2RX7TAS1R3TAS1R1 | |
| SCHEMBL3751633 | 0.70 | PARP1 (0.46) | PARP1HDAC8 | |
| SCHEMBL3418139 | 0.69 | PARP1 (0.35) | KAT6AP2RX7HCAR1PARP1MPL | |
| SCHEMBL31285075 | 0.68 | MRGPRX1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7683089-B1 | 4-(Phenylmethyl and substituted phenylmethyl)-imidazole-2-thiones acting as specific alpha2 adrenergic agonists | ALLERGAN, INC (US) | 2010-03-23 | — | — | US | disclosed |
| US-7683089-B1 | 4-(Phenylmethyl and substituted phenylmethyl)-imidazole-2-thiones acting as specific alpha2 adrenergic agonists | ALLERGAN, INC (US) | 2010-03-23 | — | — | US | disclosed |
| CN-101031549-A | As specific alpha24- (phenylmethyl and substituted phenylmethyl) -imidazole-2-thiones as adrenergic agonists | ALLERGAN INC (US) | 2007-09-05 | — | — | CN | disclosed |
| EP-1797043-A1 | 4-(PHENYLMETHYL AND SUBSTITUTED PHENYLMETHYL)-IMIDAZOLE-2-THIONES ACTING AS SPECIFIC ALPHA2 ADRENERGIC AGONISTS | Allergan, Inc. (US) | 2007-06-20 | — | — | EP | disclosed |
| WO-2006036480-A1 | 4-(PHENYLMETHYL AND SUBSTITUTED PHENYLMETHYL)-IMIDAZOLE-2-THIONES ACTING AS SPECIFIC ALPHA2 ADRENERGIC AGONISTS | ALLERGAN, INC. (US) | 2006-04-06 | — | — | WO | disclosed |